| scholarly article | Q13442814 |
| P2093 | author name string | David R Hinton | |
| Jennifer I Lim | |||
| Christine Spee | |||
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors | Q24320033 | ||
| Regulation of angiogenesis by hypoxia: role of the HIF system | Q29619187 | ||
| Detection of vascular endothelial growth factor and tumor necrosis factor alpha in epiretinal membranes of proliferative diabetic retinopathy, proliferative vitreoretinopathy and macular pucker. | Q31993188 | ||
| Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders | Q34292807 | ||
| HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs | Q35863978 | ||
| The HIF pathway as a therapeutic target | Q35876589 | ||
| Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators | Q35993096 | ||
| Hypoxia-inducible factor (HIF) in human tumorigenesis | Q36748412 | ||
| Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. | Q39737660 | ||
| Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif | Q40133024 | ||
| Hypoxia-inducible factor-1-dependent and -independent regulation of insulin-like growth factor-1-stimulated vascular endothelial growth factor secretion | Q40282441 | ||
| Coordinate Activation of HIF-1 and NF-κB DNA Binding and COX-2 and VEGF Expression in Retinal Cells by Hypoxia | Q40631714 | ||
| Expression of hypoxia-inducible factor-1alpha and the protein products of its target genes in diabetic fibrovascular epiretinal membranes | Q41943468 | ||
| Accumulation of NH2-terminal fragment of connective tissue growth factor in the vitreous of patients with proliferative diabetic retinopathy | Q44779324 | ||
| Regulation of hypoxia-inducible factor (HIF)-1 activity and expression of HIF hydroxylases in response to insulin-like growth factor I. | Q45253713 | ||
| Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals | Q46847276 | ||
| Hypoxia-Inducible Factor-1 (HIF-1) | Q61645733 | ||
| Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease | Q73101686 | ||
| High glucose concentrations alter hypoxia-induced control of vascular smooth muscle cell growth via a HIF-1alpha-dependent pathway | Q79828891 | ||
| P433 | issue | 9 | |
| P921 | main subject | hypoxia | Q105688 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1472-1478 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Retina | Q15753094 |
| P1476 | title | A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients | |
| P478 | volume | 30 |
| Q27025643 | A review of anti-VEGF agents for proliferative diabetic retinopathy |
| Q40718867 | Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy |
| Q35658383 | Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α. |
| Q48206535 | Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes |
| Q90158793 | Glucocorticoid-transactivated TSC22D3 attenuates hypoxia- and diabetes-induced Müller glial galectin-1 expression via HIF-1α destabilization |
| Q42733419 | HIF-1 is involved in high glucose-induced paracellular permeability of brain endothelial cells |
| Q38108833 | Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases |
| Q38229803 | Impaired hypoxia-inducible factor (HIF) regulation by hyperglycemia. |
| Q37825687 | Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease |
| Q41631536 | Lack of Evidence for Vasoactive and Inflammatory Mediators in the Promotion of Macular Edema Associated with Epiretinal Membranes |
| Q26827518 | Oxygen sensing in retinal health and disease |
| Q47361893 | Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration. |
| Q42620969 | Role of Hypoxia Inducible Factor 1 in Hyperglycemia-Exacerbated Blood-Brain Barrier Disruption in Ischemic Stroke |
| Q36919959 | Role of the retinal vascular endothelial cell in ocular disease |
| Q58587289 | Statement of the Professional Association of German Ophthalmologists (BVA), the German Society of Ophthalmology (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018 |
| Q40434643 | Survivin contributes to the progression of diabetic retinopathy through HIF-1α pathway |
| Q60920860 | The Different Facades of Retinal and Choroidal Endothelial Cells in Response to Hypoxia |
| Q58784813 | The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy |
| Q27028225 | Vitreous mediators in retinal hypoxic diseases |
| Q88154134 | [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018] |
Search more.